News | Enterprise Imaging | August 21, 2020

Change Healthcare Acquires Nucleus.io

Creates first of its kind end-to-end, cloud-native enterprise imaging platform

Change Healthcare announced the acquisition of Nucleus.io, a leader in the development of advanced, fully enabled, cloud-native imaging and workflow technology.

August 21, 2020 — Change Healthcare announced the acquisition of Nucleus.io, a leader in the development of advanced, fully enabled, cloud-native imaging and workflow technology.

Nucleus.io’s state-of-the-art, cloud-native imaging technology, including a zero-footprint diagnostic viewer with patented streaming technology, workflow and image sharing solutions, completes Change Healthcare’s next-generation medical imaging platform.

The transaction supports Change Healthcare’s commitment to focus on and invest in core aspects of the business to fuel long-term growth and advance innovation. This will accelerate Change Healthcare’s timeline to implement a complete cloud-based, end-to-end enterprise imaging solution with customers. Nucleus.io expands Change Healthcare’s addressable market by leveraging the over 7,500 organizations Nucleus.io currently serves.

Change Healthcare’s Enterprise Imaging Network (EIN) is the first of its kind, fully managed, cloud-native platform. The foundations of the platform, including its archive and analytics applications, have been successfully delivered to the market as a cloud-native solution. The combination of both companies’ technologies and experienced teams will enable physicians to read, diagnose, and collaborate from anywhere, reduce IT complexities, and leverage data and artificial intelligence (AI) to improve outcomes.

“Now more than ever, customers are seeking ways to lower cost, reduce complexity, protect their patient data, and deliver the best care possible. Our next-generation Enterprise Imaging Network platform helps meet those needs in ways not previously possible and delivers exceptional value to our customers,” said Tracy Byers, senior vice president and general manager, Enterprise Imaging, Change Healthcare. “This transaction will accelerate the realization of our vision and the innovation our industry has been waiting for.”

Nucleus.io’s market-leading medical image exchange solution is utilized by over 7,500 organizations across the U.S., with approximately 150 new organizations onboarding each month. Their advanced, fully enabled, cloud-native imaging technology includes a zero-footprint diagnostic viewer with patented streaming technology, workflow, and image sharing solutions, and more.

“We began our journey eight years ago with the goal of improving patient care by using the power of the web to make medical imaging instantly accessible to patients, providers, and hospitals,” said Vishal Verma, M.D., chief executive officer, NucleusHealth. “Change Healthcare was the clear choice when searching for an organization to deliver our technology to the world. We couldn’t be happier about the opportunity to have Change Healthcare bring our unified vision to light.”

For more information: www.changehealthcare.com

Related Content

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

56-Year-Old Woman With Benign Hemangioma: Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma.

News | Magnetic Resonance Imaging (MRI) | October 16, 2020
October 16, 2020 — 
Carestream Health will offer insights on technology, innovative new products and research in medical imaging through a new webinar series titled Carestream Talks. #RSNA20
News | Radiology Education | October 14, 2020
October 14, 2020 — Carestrea
The use of CT and X-ray in the assessment and treatment plan for President Trump underscores the critical role that medical imaging must play in the fight against COVID-19

A COVID-19 chest CT heat map from RADlogics

News | Artificial Intelligence | October 13, 2020
October 13, 2020 — Given recent high-profile cases of...